The effect of antithyroid treatment on atrial conduction times in patients with subclinical hyperthyroidism

Echocardiography

Volumn 29, Issue 8, 2012, Pages 950-955

  Nacar, Alper Buǧra ^a   Acar, Gürkan ^b   Yorgun, Hikmet ^a   Akçay, Ahmet ^b   Özkaya, Mesut ^b   Canpolat, Uǧur ^c   Akkoyun, Murat ^b   Tuncer, Cemal ^b  

^a ELBISTAN STATE HOSPITAL   (Turkey)

^b KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

atrial conduction time; atrial fibrillation; hyperthyroidism; tissue Doppler echocardiography

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL; THYROID HORMONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXCITATION CONTRACTION COUPLING; FEMALE; FOLLOW UP; HEART ATRIUM CONDUCTION; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUBCLINICAL HYPERTHYROIDISM; THYROID HORMONE BLOOD LEVEL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; ANTITHYROID AGENTS; FEMALE; HEART ATRIA; HEART CONDUCTION SYSTEM; HUMANS; HYPERTHYROIDISM; MALE; NEURAL CONDUCTION;

EID: 84866091467     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2012.01718.x     Document Type: Article

References (30)

1. Surks MI, Ortiz E, Daniels GH, et al,: Subclinical thyroid disease: Scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-238.
2. Parle JV, Franklyn JA, Cross KW, et al,: Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83.
3. Gammage MD, Parle JV, Holder RL, et al,: Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007; 167: 928-934.
4. Aytemir K, Ozer N, Atalar E, et al,: P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 1109-1112.
5. Dogan A, Kahraman H, Ozturk M, et al,: P wave dispersion and left atrial appendage function for predicting recurrence after conversion of atrial fibrillation and relation of p wave dispersion to appendage function. Echocardiography 2004; 21: 523-530.
6. Aras D, Maden O, Ozdemir O, et al,: Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol 2005; 99: 59-64.
7. Deniz A, Yavuz B, Aytemir K, et al,: Intra-left atrial mechanical delay detected by tissue Doppler echocardiography can be a useful marker for paroxysmal atrial fibrillation. Echocardiography 2009; 26: 779-784.
8. Omi W, Nagai H, Takamura M, et al,: Doppler tissue analysis of atrial electromechanical coupling in paroxysmal atrial fibrillation. J Am Soc Echocardiogr 2005; 18: 39-44.
9. Quinones MA, Otto CM, Stoddard M, et al,: Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167-184.
10. Devereux RB, Reichek N,: Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
11. Acar G, Sayarlioglu M, Akcay A, et al,: Assessment of atrial electromechanical coupling characteristics in patients with ankylosing spondylitis. Echocardiography 2009; 26: 549-557.
12. Fazio S, Palmieri EA, Lombardi G, et al,: Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31-50.
13. Walsh JP, Bremner AP, Bulsara MK, et al,: Subclinical thyroid dysfunction and blood pressure: A community-based study. Clin Endocrinol (Oxf) 2006; 65: 486-491.
14. Cappola AR, Fried LP, Arnold AM, et al,: Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006; 295: 1033-1041.
15. Biondi B, Cooper DS,: The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29: 76-131.
16. Wiersinga WM,: Should we treat mild subclinical/mild hyperthyroidism? Yes. Eur J Intern Med 2011; 22: 324-329.
17. Vanderpump MP,: Should we treat mild subclinical/mild hyperthyroidism? No. Eur J Intern Med 2011; 22: 330-333.
18. Biondi B, Palmieri EA, Klain M, et al,: Subclinical hyperthyroidism: Clinical features and treatment options. Eur J Endocrinol 2005; 152: 1-9.
19. Kaminski G, Michalkiewicz D, Makowski K, et al,: Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin Endocrinol (Oxf) 2011; 74: 501-507.
20. Buscemi S, Verga S, Cottone S, et al,: Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism. J Endocrinol Invest 2007; 30: 230-235.
21. Daubert JC, Pavin D, Jauvert G, et al,: Intra- and interatrial conduction delay: Implications for cardiac pacing. Pacing Clin Electrophysiol 2004; 27: 507-525.
22. Karaca M, Kinay O, Nazli C, et al,: The time interval from the initiation of the P-wave to the start of left atrial appendage ejection flow: Does it reflect interatrial conduction time? Echocardiography 2007; 24: 810-815.
23. Antonini L, Ficili S, Pasceri V, et al,: A new echo-Doppler method to measure interatrial conduction time. Validation and clinical usefulness. Minerva Cardioangiol 2011; 59: 9-15.
24. Sakabe K, Fukuda N, Fukuda Y, et al,: Interatrial dyssynchrony on tissue Doppler imaging predicts progression to chronic atrial fibrillation in patients with non-valvular paroxysmal atrial fibrillation. Heart 2009; 95: 988-993.
25. Park SM, Kim YH, Choi JI, et al,: Left atrial electromechanical conduction time can predict six-month maintenance of sinus rhythm after electrical cardioversion in persistent atrial fibrillation by Doppler tissue echocardiography. J Am Soc Echocardiogr 2010; 23: 309-314.
26. De Vos CB, Weijs B, Crijns HJ, et al,: Atrial tissue Doppler imaging for prediction of new-onset atrial fibrillation. Heart 2009; 95: 835-840.
27. Henry WL, Morganroth J, Pearlman AS, et al,: Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53: 273-279.
28. Cui QQ, Zhang W, Wang H, et al,: Assessment of atrial electromechanical coupling and influential factors in nonrheumatic paroxysmal atrial fibrillation. Clin Cardiol 2008; 31: 74-78.
29. Guntekin U, Gunes Y, Simsek H, et al,: P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment. Indian Pacing Electrophysiol J 2009; 9: 251-259.
30. Katircibasi MT, Deniz F, Pamukcu B, et al,: Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism. Exp Clin Endocrinol Diabetes 2007; 115: 376-379.